Navigation Links
Study of Iraq veterans' traumatic brain injuries to be conducted by UB researchers
Date:1/30/2009

BUFFALO, N.Y. Traumatic brain injury (TBI) has been identified as the "signature injury" of the wars in Iraq and Afghanistan.

TBI is known to cause deficits in memory, attention and decision-making and often occurs in conjunction with post-traumatic stress disorder (PTSD), depression, anxiety disorders and substance abuse.

An estimated 150,000 U.S. veterans have been diagnosed with TBI, based on statistics gathered by the Veterans Administration's (VA) Quality Enhancement Research Initiative, known as QUERI.

While the numbers are relatively easy to assemble, the long-term cognitive and affective consequences of TBI and the effect on veterans' quality of life are not well understood, according to the VA, and evidence-based guidelines for diagnosis and treatment are limited. To be prepared to meet the needs of these veterans over time, the VA's Health Services Research & Development Unit is funding a $1.4 million, four-year prospective cohort study of Iraq and Afghanistan-era veterans, headed by University at Buffalo researchers at the Buffalo VA Medical Center. The results will be used nationwide.

VA medical centers in Albany, Syracuse, Bath and Canandaigua/Rochester also will participate in the study. Kerry T. Donnelly, Ph.D., UB adjunct assistant professor in the Department of Counseling, School and Educational Psychology and clinical assistant professor in the Department of Psychiatry, is principal investigator.

The Department of Counseling, School and Educational Psychology is in the UB Graduate School of Education, while the Department of Psychiatry is part of the UB School of Medicine and Biomedical Sciences.

"This project began here at the Buffalo VA in June 2008," said Donnelly. "While the Departments of Defense and Veterans Affairs have worked well in concert to address the needs of service members with major injuries, such as limb loss or severe TBI, veterans who might have more subtle co
'/>"/>

Contact: Lois Baker
ljbaker@buffalo.edu
716-645-5000 x1417
University at Buffalo
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Study confirms persistence of diversity problems in academic medicine
2. Oncogene inhibits tumor suppressor to promote cancer: Study links B-RAF and LKB1
3. Perceptions and experiences of homeless youth vary by race, UCSF study shows
4. New Study: Protein in the Morning Helps Dieters Stay on Track and Keep Weight Off
5. New study explores the relationship between preterm birth and autism spectrum disorder
6. Study finds preemies more likely to score positive
7. Weight loss reduces incontinence in obese women, UCSF study shows
8. Weight Loss Reduces Incontinence In Obese Women, UCSF Study Shows
9. Study shows younger women with endometrial cancer can safely keep ovaries, avoid early menopause
10. New study highlights the distress of medical staff
11. Controversial Chemical Lingers Longer in the Body: Study

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)... After suffering from women,s hair loss...rowing back and she,s sharing her progress and the... women through the release of her video diaries wh... and during her treatment. , ...r loss sufferer Zsanett Siklosi has released the ...
(Date:11/23/2009)...O,Pa.,Nov.23/PRNewswire-FirstCall/--InfoLogix,Inc....risemobilitysolutionsforthehealthcareandcommercial...identofManagedServicesatSiemensHealthServices,hasj...Services. ,, (Logo: http://www.newscom.com/cgi-...entofStrategicHealthcareServicesforInfoLogix,Mr.Wa...
(Date:11/23/2009)...rs of cancer patients and survivors treated with c...t often become chronic conditions, hindering patie...ists at the University of Rochester Medical Center...xperienced sleep troubles at nearly three times th...more prevalent in younger patients and those with ...
(Date:11/23/2009)...w their odds drop by 63 percent with moderate-to-h...23 (HealthDay News) -- Moderate-to-high intensity ...elp reduce stroke risk in older men but not in wom...most 3,300 men and women, average age 69, in Manha...g that time, there were 238 strokes among the part...
(Date:11/23/2009)...p weaknesses of drug approval process in United St...3 (HealthDay News) -- Problems with the popular ar...eart attack, stroke and death, were known for year...market in 2004, a new report says. , Contrary ...ngerous side effects were evident in 2000, a year ...
Breaking Medicine News(10 mins):Health News:Women's Hair Loss Treatment Results Captured on Video to Inspire Others 2Health News:Women's Hair Loss Treatment Results Captured on Video to Inspire Others 3Health News:Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services 2Health News:Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services 3Health News:Insomnia prevalent among cancer patients who receive chemotherapy 2Health News:Vigorous Exercise Cuts Stroke Risk for Men, Not Women 2Health News: Vioxx Problems Known Years Before Recall 2Health News: Vioxx Problems Known Years Before Recall 3Health News: Vioxx Problems Known Years Before Recall 4
...with cervical spinal injury may have more damage t...hed in the Annals of Emergency Medicine, say that ...n patients over and above the normal X-rays.// ...re than a third of patients who were thought to ha...
..., researchers from University of South Florida had...Gerontology: Psychological Sciences that the more ... may have a role to play in reducing the risk of d... and dementia in general. Researchers had discover...
Dengue, the mosquito-transmitted lethal disease that has claimed 15 lives and afflicted 1,000 people in West Bengal so far, has been declared an epidemic by the state government.// State Health Di
...tment of had discovered a new way to test the stem...// The researchers had used a non-invasive i... trace stem cells’ destinations after being inject... myocardial infarctions in seven dogs, six of whic...
...l significantly reduces the spread of gastrointest...ilies studied, half of the families, which used th... in the spread of illness related to the gastroint...zer and educational materials on hand hygiene. The...
...ve that governs the flow of blood into a large blo...o various organs of the body. // It prevents the b...est of the body. The effective functioning of.... The defect can be present right form birth or it...
Other Medicine News:Health News:Alcohol based sanitizer found to reduce illness in families 2Health News:Percutaneous aortic valve replacement- a revolution in Cardiac Surgery 2
(Date:11/23/2009)...,Nov.23/PRNewswire-USNewswire/--JubilantOrganosys,...nResearchInstitutetodayannouncedajointventurethatw...ablingtechnologiesintheareasofOncology,MetabolicDi...bitragedandleveragedpartnershipthatwillacceleratet...wide.AMemorandumofUnderstandingwassignedtodayinWas...
(Date:11/23/2009)...-BioTrendsResearchGroup,Inc.releasedWave2ofits La...lti-phasesyndicatedmarketresearchprojecttrackingth...efirstsixmonthsofproductavailability.Eachwaveofthe...ephrologistsandqualitativeinformationfromasubsetof...touse,reasonstouse,typicalpatienttypes,productperc...
(Date:11/23/2009)...rstCall/--CordBloodAmerica,Inc.(OTCBulletinBoard:C...any( http://www.cordblood-america.com )focusedonbr...linsurancepolicy,tofamiliesnationwideandinternatio...withCEOandco-founderMatthewSchisslerisnowavailable...e/2875811 . ,, Intheinterview,Mr.Schisslerupdat...
Breaking Medicine Technology:Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 2Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 3Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 4Reported Use of AMAG's Feraheme (ferumoxytol) Continues To Be Low, But a Number of Nephrologists Are 'On the Verge' of Use 2Canadian Cancer Society Selects Branded Merchandise Solutions From Boundless Network 61066 1Canadian Cancer Society Selects Branded Merchandise Solutions From Boundless Network 61066 2Canadian Cancer Society Selects Branded Merchandise Solutions From Boundless Network 61066 3Regado Biosciences to Present at the Ninth Annual Joint Symposium of BioNJ and Pennsylvania Bio on November 16 2009 14777 1Regado Biosciences to Present at the Ninth Annual Joint Symposium of BioNJ and Pennsylvania Bio on November 16 2009 14777 2PLC Systems Reports Third Quarter 2009 Results 3B Announces Distribution Agreement for RenalGuard 28R 29 in Brazil 6136 1PLC Systems Reports Third Quarter 2009 Results 3B Announces Distribution Agreement for RenalGuard 28R 29 in Brazil 6136 2PLC Systems Reports Third Quarter 2009 Results 3B Announces Distribution Agreement for RenalGuard 28R 29 in Brazil 6136 3PLC Systems Reports Third Quarter 2009 Results 3B Announces Distribution Agreement for RenalGuard 28R 29 in Brazil 6136 4PLC Systems Reports Third Quarter 2009 Results 3B Announces Distribution Agreement for RenalGuard 28R 29 in Brazil 6136 5PLC Systems Reports Third Quarter 2009 Results 3B Announces Distribution Agreement for RenalGuard 28R 29 in Brazil 6136 6
...to Timeline for Second Pivotal Phase 3 Trial CL-05... Advanced Life,Sciences Holdings, Inc. , today ann...ata from Trial CL-06, the first of two,pivotal Pha... and,effectiveness of cethromycin, a novel once-a-...uired pneumonia (CAP). The Company,also provided a...
..., July 2, 2007-Women with at least three sites of,...times more likely,than average women to develop br...c Cancer Center led study of women with atypical,h... 1 issue of the,Journal of Clinical Oncology., Sev...erplasia,(also called atypia) in breast tissue is ...
Other Medicine Technology:Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 2Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 3Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 4Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 5Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 6Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 7Mayo Clinic News Release: Mayo Clinic-led Study Improves Breast,Cancer Risk Prediction in Women with Atypia 2Mayo Clinic News Release: Mayo Clinic-led Study Improves Breast,Cancer Risk Prediction in Women with Atypia 3
...xperience the finest surgical-quality loupes avail...andard for innovative optical design, combining su...livering optimum performance with maximum comfort,...al professionals worldwide. All SheerVision loupes...
...xperience the finest surgical-quality loupes avail...andard for innovative optical design, combining su...ivering optimum performance with maximum comfort, ...l professionals worldwide. Make both a professiona...
...hese award-winning surgical loupes from SheerVisio...resolution optics combined with light-weight comfo...s weight as little as 1.5 ounces when included wit...in either a flip-up or through-the-lens (TTL) desi...
...heerVision is now the first manufacturer to offer ...he wearer. These next generation loupes feature ex...tra-lightweight design, and are multi-coated lens ...With SheerVision's proprietary SureFit system - yo...
Medicine Products: